Clinical Trial Update: The Efficacy and Safety of HCQ Plus Pred in ANA Positive ITP [NA]

View source ↗

Summary

A clinical trial is evaluating the efficacy and safety of hydroxychloroquine plus prednisone in ANA-positive immune thrombocytopenia; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immune Thrombocytopenia

Drugs mentioned

• Hydroxychloroquine (hydroxychloroquine)
• PREDNISONE (Prednisone)

Snippet

Sponsor: Yunfeng Cheng | Conditions: Immune Thrombocytopenia With Positive ANA Antibodies | NA | Status: RECRUITING